Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03685448
Title ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) (UNICAB)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Indications

papillary renal cell carcinoma

renal carcinoma

chromophobe renal cell carcinoma

sarcomatoid renal cell carcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries


No variant requirements are available.